![]() ![]() "The more people who get vaccinated, the faster we're going to overcome this virus and get back to our loved ones, get our economy back on track, and start to move back to normal," President Biden said earlier this month, after announcing news of Johnson & Johnson's deal with Merck. Of the remaining vaccines that the Trump administration's Operation Warp Speed poured billions of dollars into developing and manufacturing, the shot developed by AstraZeneca and Oxford University is likely next to be greenlit by the Food and Drug Administration.ĪstraZeneca executive Ruud Dobber told CBSN the company hoped to receive results of their clinical trial "in the next few weeks," potentially clearing millions more shots of a vaccine already being distributed in several other countries. And millions more doses from other drugmakers may soon be added to the looming surplus of shots, as companies await results of trials from their own vaccine candidates. Biden announced the purchase of another 100 million doses of Johnson & Johnson's vaccine. The Biden administration brokered a deal earlier this month with rival pharmaceutical manufacturer Merck to produce millions of doses of the single-shot Johnson & Johnson vaccine, which will rapidly accelerate the supply. government, with a total of 400 million doses from both promised by the end of May. The companies have so far delivered nearly a third of their orders to the U.S. Pfizer and Moderna, whose vaccines require two doses, say they plan to supply a combined 600 million doses of their COVID-19 vaccines through July, enough to immunize 300 million people. State and federal officials say a coming surge in supply will alleviate the largest obstacle to scaling up the campaign. The nationwide pace of vaccinations has quickened to an average of over 2 million doses a day. And providers faced steep challenges distributing the vaccines made by Pfizer and Moderna, which spoil if left too long outside their freezers. Many of those prioritized first for the shots faced frustrating waits and complicated scheduling systems to get their doses. ![]() ![]() population has yet to be fully vaccinated, amid worrying reports of highly contagious variants of the virus spreading across the country. Clinical trials in teens and children could clear the way for some shots for adolescents by the fall and younger children in early 2022. The Biden administration now estimates it will have enough doses available for every adult by May. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |